Prevail Therapeutics
7 Decision Makers · 3 Verified Contacts & Email Format
- Employees
- 51-100
- Founded
- 2017
- Listing
- For Profit · NASDAQ:PRVL
- Headquarters
- New York, NY
Company data last updated Jul 28, 2025.
About Prevail Therapeutics
Prevail Therapeutics is a biotechnology company focused on developing novel gene therapies for patients with Parkinson’s disease.
Who to contact at Prevail Therapeutics
Email Format
Leadership & Decision Makers
Contact details of 7 Prevail Therapeutics decision makers
David Litwack
Jeremiah Hendricks
Li Chin Wong
Franz Hefti
Jeffrey Sevigny
Yong Dai
Asa Abeliovich
General Emails
General company emails, e.g. customer support lines
Similar Companies like Prevail Therapeutics
Citi Venture Capital International
HQ: New York, NY
Blackstone Group
HQ: New York, NY
Morgan Stanley Investment Management
HQ: New York, NY
JPMorgan Partners
HQ: New York, NY
Records are compiled from publicly available sources and checked as described in our methodology. Company data last updated Jul 28, 2025.
Frequently Asked Questions about Prevail Therapeutics
What does Prevail Therapeutics do?
Prevail Therapeutics is a biotechnology company focused on developing novel gene therapies for patients with Parkinson’s disease.
Where is Prevail Therapeutics headquartered?
Prevail Therapeutics is headquartered in New York, NY.
When was Prevail Therapeutics founded?
Prevail Therapeutics was founded in 2017.
How many employees does Prevail Therapeutics have?
Prevail Therapeutics has approximately 51-100 employees.
What industry is Prevail Therapeutics in?
Prevail Therapeutics operates in the Finance & Banking industry.
What is the email format for Prevail Therapeutics?
The most common email format at Prevail Therapeutics is {first_name}.{last_name}@prevailtherapeutics.com. For example: firstname.lastname@prevailtherapeutics.com.
How do I contact Prevail Therapeutics?
You can contact Prevail Therapeutics via email at info@prevailtherapeutics.com or admin@prevailtherapeutics.com, headquartered in New York, NY.